Genetic Underpinnings of Ethnic Disparities in Bone Toxicities Between Hispanic and Non-Hispanic Children Treated for Acute Lymphoblastic Leukemia

PC1 - First significant principal components from Eigenstrat analysis within each population (EUR: 3 PCs, ASN: 1 PC, HIS: 2 PCs, AFR: 1 PC, OTH: 6 PCs) (phv00487958.v1.p1)
PC1 - First significant principal components from Eigenstrat analysis within each population (phv00536939.v1.p1)
PC2 - Second significant principal components from Eigenstrat analysis within each population (EUR: 3 PCs, ASN: 1 PC, HIS: 2 PCs, AFR: 1 PC, OTH: 6 PCs) (phv00487959.v1.p1)
PC2 - Second significant principal components from Eigenstrat analysis within each population (phv00536940.v1.p1)
PC3 - Third significant principal components from Eigenstrat analysis within each population (EUR: 3 PCs, ASN: 1 PC, HIS: 2 PCs, AFR: 1 PC, OTH: 6 PCs) (phv00487960.v1.p1)
PC3 - Third significant principal components from Eigenstrat analysis within each population (phv00536941.v1.p1)
PC4 - Fourth significant principal components from Eigenstrat analysis within each population (EUR: 3 PCs, ASN: 1 PC, HIS: 2 PCs, AFR: 1 PC, OTH: 6 PCs) (phv00487961.v1.p1)
PC5 - Fifth significant principal components from Eigenstrat analysis within each population (EUR: 3 PCs, ASN: 1 PC, HIS: 2 PCs, AFR: 1 PC, OTH: 6 PCs) (phv00487962.v1.p1)
PC6 - Sixth significant principal components from Eigenstrat analysis within each population (EUR: 3 PCs, ASN: 1 PC, HIS: 2 PCs, AFR: 1 PC, OTH: 6 PCs) (phv00487963.v1.p1)

age_yrs - Subject age at diagnosis (phv00487955.v1.p1)
age_yrs - Subject age at diagnosis (phv00536936.v1.p1)
sex - Biological sex (phv00487956.v1.p1)
sex - Biological sex (phv00536937.v1.p1)
SEX - Biological sex (phv00487949.v2.p1)

ANALYTE_TYPE - Analyte type of sample (phv00487967.v2.p1)
BODY_SITE - Collection site of sample (phv00487966.v2.p1)
cmp_btox - Status of bone toxicity (phv00487954.v1.p1)
cmp_btox - Status of bone toxicity (phv00536935.v1.p1)
cmp_btoxt - Time to bone toxicity (phv00487953.v1.p1)
cmp_btoxt - Time to bone toxicity (phv00536934.v1.p1)
COHORT - Cohort (phv00536943.v1.p1)
CONSENT - Consent group as determined by DAC (phv00487948.v2.p1)
finalrisk - Final risk group (phv00487957.v1.p1)
finalrisk - Final risk group (phv00536938.v1.p1)
IS_TUMOR - Tumor status of sample (phv00487968.v2.p1)
SAMPLE_ID - Sample ID (phv00487965.v2.p1)
SAMPLE_ID - Sample ID (phv00487951.v2.p1)
SUBJECT_ID - Subject ID (phv00487952.v1.p1)
SUBJECT_ID - Subject ID (phv00536933.v1.p1)
SUBJECT_ID - Subject ID (phv00487947.v2.p1)
SUBJECT_ID - Subject ID (phv00487950.v2.p1)